Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma

Clinical trial NCT06995105 · RECRUITING

Trial details

NCT number: NCT06995105
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma (HCC)

Start date: 2025-04-09
Primary completion: 2027-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.